Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


The Angels Initiative

Stroke prevention


  Liver Diseases

  Free Subscription


Articles published in Am J Gastroenterol

Retrieve available abstracts of 202 articles:
HTML format



Single Articles


    June 2022
  1. BAJAJ JS, Wong F, Kamath PS, Lai JC, et al
    Acute-on-Chronic Liver Failure.
    Am J Gastroenterol. 2022;117:831-834.
    PubMed    


  2. SCORLETTI E, Creasy KT, Vujkovic M, Vell M, et al
    Dietary Vitamin E Intake Is Associated With a Reduced Risk of Developing Digestive Diseases and Nonalcoholic Fatty Liver Disease.
    Am J Gastroenterol. 2022;117:927-930.
    PubMed     Abstract available


  3. KANN AE, Jepsen P, Madsen LG, Crooks C, et al
    Motivation to Reduce Drinking and Engagement in Alcohol Misuse Treatment in Alcohol-Related Liver Disease: A National Health Survey.
    Am J Gastroenterol. 2022;117:918-922.
    PubMed     Abstract available


    May 2022
  4. ACHANTA CR, Kinhal SV, Imandi V, Singh A, et al
    Motorized Spiral Enteroscope Guided Biliary Intervention for Treatment of Biliary Obstruction in Patient with HepaticoJejunostomy.
    Am J Gastroenterol. 2022 May 9. pii: 00000434-990000000-00372.
    PubMed    


  5. CROCOMBE D, Freemantle N, O'Brien A
    Additional Analyses for the Published Primary Norfloxacin Prophylaxis for APASL-Defined Acute-on-Chronic Liver Failure.
    Am J Gastroenterol. 2022;117:814-815.
    PubMed    


  6. MIR BA, Majeed T, Chauhan A
    A New Window to Favorable Outcome in Acute-on-Chronic Liver Failure.
    Am J Gastroenterol. 2022;117:815.
    PubMed    


    April 2022
  7. RASHMI KG, Sahoo J
    Correspondence from Rashmi et al " Effect of Vitamin D Supplementation on Vitamin D Level and Bone Mineral Density in Patients With Cirrhosis: A Randomized Clinical Trial ".
    Am J Gastroenterol. 2022 Apr 15. pii: 00000434-990000000-00344.
    PubMed    


  8. TAPPER EB, Salim N, Baki J, Zhao Z, et al
    Pickle Juice Intervention for Cirrhotic Cramps Reduction: The PICCLES Randomized Controlled Trial.
    Am J Gastroenterol. 2022 Apr 13. pii: 00000434-990000000-00331.
    PubMed     Abstract available


  9. RAO A, Rule JA, Hameed B, Ganger D, et al
    Secular Trends in Severe Idiosyncratic Drug-Induced Liver Injury in North America: An Update From the Acute Liver Failure Study Group Registry.
    Am J Gastroenterol. 2022;117:617-626.
    PubMed     Abstract available


  10. KULKARNI AV, Tirumalle S, Premkumar M, Kumar K, et al
    Primary Norfloxacin Prophylaxis for APASL-Defined Acute-on-Chronic Liver Failure: A Placebo-Controlled Double-Blind Randomized Trial.
    Am J Gastroenterol. 2022;117:607-616.
    PubMed     Abstract available


    March 2022
  11. SHAHA S, Gao Y, Huang J, Imbertson E, et al
    Successful Treatment of Superior Mesenteric Artery Syndrome with Percutaneous Endoscopic Gastrojejunostomy in a Sarcopenic Patient with Cirrhosis.
    Am J Gastroenterol. 2022 Mar 28. pii: 00000434-990000000-00308.
    PubMed    


  12. LAMMERT C, Toal E, Mathur K, Khungar V, et al
    Large Hepatic Adenomas and Hepatic Adenomatosis: A multicenter study of risk factors, interventions, and complications.
    Am J Gastroenterol. 2022 Mar 23. pii: 00000434-990000000-00302.
    PubMed     Abstract available


  13. COSTA MS, Agostinho C, Figueiredo P
    Abdominal Wall Invasion of Hepatocellular Carcinoma.
    Am J Gastroenterol. 2022 Mar 16. pii: 00000434-990000000-00288.
    PubMed    


  14. VIEIRA BARBOSA J, Milligan S, Frick A, Broestl J, et al
    Fibrosis-4 Index Can Independently Predict Major Adverse Cardiovascular Events in Nonalcoholic Fatty Liver Disease.
    Am J Gastroenterol. 2022;117:453-461.
    PubMed     Abstract available


  15. DUARTE-ROJO A, Sejdic E
    Artificial Intelligence and the Risk for Intuition Decline in Clinical Medicine.
    Am J Gastroenterol. 2022;117:401-402.
    PubMed     Abstract available


  16. LEE HL, Lin MC, Yeh FC, Tsai MK, et al
    Klebsiella pneumoniae Invasive Syndrome With Ventriculitis.
    Am J Gastroenterol. 2022;117:372.
    PubMed    


    February 2022
  17. UFERE NN, Patzer RE, Kavalieratos D, Louissaint J, et al
    Rural-Urban Disparities in Mortality from Cirrhosis in the United States from 1999 to 2019.
    Am J Gastroenterol. 2022 Feb 25. pii: 00000434-990000000-00270.
    PubMed    


  18. LEVY MJ, Bendel EC, Bjarnason H, Reisenauer CJ, et al
    Endoscopic Ultrasound Guided Dual Ultrasound Hepatic Cyst Aspiration and Sclerotherapy to Ameliorate Portal Hypertension.
    Am J Gastroenterol. 2022 Feb 17. pii: 00000434-990000000-00261.
    PubMed    


  19. LEONTIADIS GI, Longstreth GF
    Evolutionary medicine perspectives: H. pylori, lactose intolerance, and three hypotheses for functional and inflammatory gastrointestinal and hepatobiliary disorders.
    Am J Gastroenterol. 2022 Feb 15. pii: 00000434-990000000-00250.
    PubMed     Abstract available


  20. ZHAO Y, Li X, Yang S, Tao Y, et al
    Small-Diameter Drug-Eluting Beads-Based Transarterial Chemoemboli-zation (DEB-TACE) for Treating Patients With Esophageal Cancer With Acute Bleeding.
    Am J Gastroenterol. 2022 Feb 8. pii: 00000434-990000000-00244.
    PubMed    


  21. PENG T, Lu H, Deng L, Li Q, et al
    Diffuse intrahepatic bile duct hamartomas.
    Am J Gastroenterol. 2022 Feb 3. pii: 00000434-990000000-00241.
    PubMed    


  22. BAJAJ JS, O'Leary JG, Lai JC, Wong F, et al
    Acute-on-Chronic Liver Failure Clinical Guidelines.
    Am J Gastroenterol. 2022;117:225-252.
    PubMed     Abstract available


  23. VAN KLEEF LA, Hofman A, Voortman T, de Knegt RJ, et al
    Objectively Measured Physical Activity Is Inversely Associated With Nonalcoholic Fatty Liver Disease: The Rotterdam Study.
    Am J Gastroenterol. 2022;117:311-318.
    PubMed     Abstract available


  24. YU S, Pan L, Ma J, Cao H, et al
    The Underlying Cause of Esophageal Variceal Bleeding: Hereditary Thrombophilia.
    Am J Gastroenterol. 2022;117:217.
    PubMed    


    January 2022
  25. YUAN L, Hanlon CL, Terrault N, Alqahtani S, et al
    Portrait of Regional Trends in Liver Transplantation for Nonalcoholic Steatohepatitis in the United States.
    Am J Gastroenterol. 2022 Jan 27. pii: 00000434-990000000-00229.
    PubMed     Abstract available


  26. LOUISSAINT J, Grzyb K, Bashaw L, Mohammad RA, et al
    An Electronic Decision Support Intervention Reduces Readmissions for Patients With Cirrhosis.
    Am J Gastroenterol. 2022 Jan 12. pii: 00000434-990000000-00194.
    PubMed     Abstract available


  27. GONZALEZ SA, Velez JCQ
    Board Review Vignette: Lessons Learned in the Management of Hepatorenal Syndrome Type 1 with Terlipressin.
    Am J Gastroenterol. 2022 Jan 5. pii: 00000434-990000000-00198.
    PubMed    


    December 2021
  28. AHN JC, Attia ZI, Rattan P, Mullan AF, et al
    Development of the AI-Cirrhosis-ECG (ACE) Score: An electrocardiogram-based deep learning model in cirrhosis.
    Am J Gastroenterol. 2021 Dec 29. pii: 00000434-990000000-00204.
    PubMed     Abstract available


  29. KIM NJ, Rozenberg-Ben-Dror K, Jacob DA, Berry K, et al
    The COVID-19 pandemic highlights opportunities to improve hepatocellular carcinoma screening and diagnosis in a national health system: COVID-19 and HCC screening and diagnosis.
    Am J Gastroenterol. 2021 Dec 29. pii: 00000434-990000000-00201.
    PubMed     Abstract available


  30. HUANG AC, Grab J, Flemming JA, Dodge JL, et al
    Pregnancies With Cirrhosis Are Rising and Associated With Adverse Maternal and Perinatal Outcomes.
    Am J Gastroenterol. 2021 Dec 20. pii: 00000434-990000000-00172.
    PubMed     Abstract available


  31. VAN DE BRUAENE C, Houthoofd B, De Coninck S
    A Hepatic Change of Mind.
    Am J Gastroenterol. 2021 Dec 20. pii: 00000434-990000000-00169.
    PubMed    


  32. CACOUB P, Asselah T
    Hepatitis B Virus Infection and Extra-Hepatic Manifestations: A Systemic Disease.
    Am J Gastroenterol. 2021 Dec 16. pii: 00000434-990000000-00166.
    PubMed     Abstract available


  33. LV Y, Bai W, Li K, Wang Z, et al
    Correction to: Anticoagulation and Transjugular Intrahepatic Portosystemic Shunt for the Management of Portal Vein Thrombosis in Cirrhosis: A Prospective Observational Study.
    Am J Gastroenterol. 2021 Dec 9. pii: 00000434-990000000-00159.
    PubMed    


  34. LIZAOLA-MAYO BC, Mathur AK, Borad MJ, Jadlowiec CC, et al
    Immunotherapy as a Downstaging Tool for Liver Transplantation in Hepatocellular Carcinoma.
    Am J Gastroenterol. 2021;116:2478-2480.
    PubMed    


  35. HARRISON SA, Baum SJ, Gunn NT, Younes ZH, et al
    Safety, Tolerability, and Biologic Activity of AXA1125 and AXA1957 in Subjects With Nonalcoholic Fatty Liver Disease.
    Am J Gastroenterol. 2021;116:2399-2409.
    PubMed     Abstract available


  36. BERK C, Ammar T, Lee BT
    Acute Liver Failure due to Manufactured Alkaline Water: A Case Series of "Real Water"-Induced Liver Injury.
    Am J Gastroenterol. 2021;116:2476-2477.
    PubMed    


  37. MEDAS R, Garrido I, Coelho R, Macedo G, et al
    Extensive Abdominal Wall Hematoma After Paracentesis.
    Am J Gastroenterol. 2021;116:2325.
    PubMed    


    November 2021
  38. KEHAR M, Griffiths R, Flemming JA
    Increasing Incidence of Cirrhosis Over the Past 2 Decades Among Children in Ontario, Canada.
    Am J Gastroenterol. 2021 Nov 18. pii: 00000434-990000000-00150.
    PubMed     Abstract available


  39. DAWOD E, Nieto J, Saab S
    Endoscopic Ultrasound-Guided Liver Biopsy: Where Do We Stand?
    Am J Gastroenterol. 2021 Nov 17. pii: 00000434-990000000-00146.
    PubMed    


  40. DUONG NK, Shrestha S, Park D, Shahab O, et al
    Bristol Stool Scale as a Determinant of Hepatic Encephalopathy Management in Patients With Cirrhosis.
    Am J Gastroenterol. 2021 Nov 5. pii: 00000434-990000000-00135.
    PubMed     Abstract available


  41. YANG D, Zhuang B, Xie X
    Hepatic Angiofibroma of Soft tissue: A Case Report.
    Am J Gastroenterol. 2021 Nov 4. pii: 00000434-990000000-00140.
    PubMed    


  42. KIM Y, Chang Y, Kwon MJ, Hong YS, et al
    Fasting Ketonuria and the Risk of Incident Nonalcoholic Fatty Liver Disease With and Without Liver Fibrosis in Nondiabetic Adults.
    Am J Gastroenterol. 2021;116:2270-2278.
    PubMed     Abstract available


    October 2021
  43. WEBER S, Gerbes AL
    Ashwagandha-Induced Liver Injury: Self-Reports on Commercial Websites as Useful Adjunct Tools for Causality Assessment.
    Am J Gastroenterol. 2021;116:2151-2152.
    PubMed    


  44. GAO X, Gao Y, Ye X, Kang W, et al
    Rare Multiple Liver Lesions With Concentric Circle Pattern.
    Am J Gastroenterol. 2021;116:1979.
    PubMed    


  45. LIN FP, Visina JM, Bloomer PM, Dunn MA, et al
    Prehabilitation-Driven Changes in Frailty Metrics Predict Mortality in Patients With Advanced Liver Disease.
    Am J Gastroenterol. 2021;116:2105-2117.
    PubMed     Abstract available


  46. BOIKE JR, Mazumder NR, Kolli KP, Ge J, et al
    Outcomes After TIPS for Ascites and Variceal Bleeding in a Contemporary Era-An ALTA Group Study.
    Am J Gastroenterol. 2021;116:2079-2088.
    PubMed     Abstract available


  47. JOHNSON DA
    "Sickeningly Sweet".... High-Fructose Corn Syrup-Caveat Emptor!
    Am J Gastroenterol. 2021;116:1970-1971.
    PubMed    


    September 2021
  48. TRIPATHI PR, Sen Sarma M, Yachha SK, Aggarwal A, et al
    Relative Adrenal Insufficiency in Decompensated Cirrhotic Children: Does It Affect Outcome?
    Am J Gastroenterol. 2021 Sep 10. pii: 00000434-990000000-00094.
    PubMed     Abstract available


  49. LEE HW, Park SY, Lee YR, Lee H, et al
    Episodic Detectable Viremia Does Not Affect Prognosis in Untreated Compensated Cirrhosis With Serum Hepatitis B Virus DNA <2,000 IU/mL.
    Am J Gastroenterol. 2021 Sep 10. pii: 00000434-990000000-00096.
    PubMed     Abstract available


  50. CHINA L, Freemantle N, Forrest E, Kallis Y, et al
    Targeted Albumin Therapy Does Not Improve Short-Term Outcome in Hyponatremic Patients Hospitalized With Complications of Cirrhosis: Data From the ATTIRE Trial.
    Am J Gastroenterol. 2021 Sep 9. pii: 00000434-990000000-00104.
    PubMed     Abstract available


  51. SHAH BJ, Onken JE, Edgar L, Jou JH, et al
    Development of gastroenterology and transplant hepatology milestones 2.0: a guide for programs, faculty, and fellows.
    Am J Gastroenterol. 2021 Sep 7. pii: 00000434-990000000-00088.
    PubMed    


  52. BLOOM PP, Robin J, Xu M, Arvind A, et al
    Hepatic Encephalopathy is Associated With Slow Speech on Objective Assessment.
    Am J Gastroenterol. 2021;116:1950-1953.
    PubMed     Abstract available


  53. CASTELLANA M, Donghia R, Guerra V, Procino F, et al
    Fibrosis-4 Index vs Nonalcoholic Fatty Liver Disease Fibrosis Score in Identifying Advanced Fibrosis in Subjects With Nonalcoholic Fatty Liver Disease: A Meta-Analysis.
    Am J Gastroenterol. 2021;116:1833-1841.
    PubMed     Abstract available


  54. THULUVATH PJ, Alukal JJ, Zhang T
    A Scoring Model to Predict In-Hospital Mortality in Patients With Budd-Chiari Syndrome.
    Am J Gastroenterol. 2021;116:1905-1912.
    PubMed     Abstract available


    August 2021
  55. SACK JS, Liu AF, Gray M, Roat J, et al
    Association of Terry Nails With Liver Cirrhosis.
    Am J Gastroenterol. 2021 Aug 27. pii: 00000434-990000000-00085.
    PubMed     Abstract available


  56. FU XL, Chen HL
    COVID-19 Vaccine for Chronic Gastroenterology and Hepatology Patients: A Need for Better Evidence.
    Am J Gastroenterol. 2021 Aug 17. pii: 00000434-990000000-00073.
    PubMed    


  57. RODRIGUEZ M, Gonzalez-Dieguez ML, Varela M, Cadahia V, et al
    Impact of Alcohol Abstinence on the Risk of Hepatocellular Carcinoma in Patients With Alcohol-Related Liver Cirrhosis.
    Am J Gastroenterol. 2021 Aug 16. pii: 00000434-990000000-00111.
    PubMed     Abstract available


  58. SCHNEIDER CV, Fromme M, Schneider KM, Bruns T, et al
    Mortality in Patients With Genetic and Environmental Risk of Liver Disease.
    Am J Gastroenterol. 2021;116:1741-1745.
    PubMed     Abstract available


  59. TAGUCHI YV, Snyder DL, Shah JB, Dickson RC, et al
    Deglutition Syncope After Variceal Band Ligation.
    Am J Gastroenterol. 2021;116:1763.
    PubMed    


  60. HASHEMIAN M, Merat S, Poustchi H, Jafari E, et al
    Red Meat Consumption and Risk of Nonalcoholic Fatty Liver Disease in a Population With Low Meat Consumption: The Golestan Cohort Study.
    Am J Gastroenterol. 2021;116:1667-1675.
    PubMed     Abstract available


    July 2021
  61. MOCTEZUMA-VELAZQUEZ C, Abraldes JG
    Statins and Liver Cancer in Cirrhosis: The Most Relevant Questions Are Still Unanswered.
    Am J Gastroenterol. 2021 Jul 19. pii: 00000434-990000000-00051.
    PubMed     Abstract available


  62. LABENZ C, Labenz J
    Proton Pump Inhibitors in Patients With Liver Cirrhosis: Evidence to Improve Their Battered Reputation.
    Am J Gastroenterol. 2021 Jul 19. pii: 00000434-990000000-00048.
    PubMed    


  63. USHIDA K, Shimizu M, Yamamoto Y, Momosaki R, et al
    Strategies to Improve Exercise Adherence in Patients With Cirrhosis.
    Am J Gastroenterol. 2021 Jul 13. pii: 00000434-990000000-00043.
    PubMed    


  64. PINYOPORNPANISH K, Al-Yaman W, Butler RS, Carey W, et al
    Chemopreventive Effect of Statin on Hepatocellular Carcinoma in Patients With Nonalcoholic Steatohepatitis Cirrhosis.
    Am J Gastroenterol. 2021 Jul 2. pii: 00000434-990000000-00036.
    PubMed     Abstract available


  65. MATTOS AZ, Leao GS, Bombassaro IZ, Chiesa T, et al
    Definitions for Acute-on-Chronic Liver Failure: In Dubio Pro Reo.
    Am J Gastroenterol. 2021;116:1550.
    PubMed    


  66. VAN J, Aloman C, Reau N
    Potential Bias and Misconceptions in Liver Transplantation for Alcohol- and Obesity-Related Liver Disease.
    Am J Gastroenterol. 2021 Jul 1. pii: 00000434-990000000-00032.
    PubMed     Abstract available


    June 2021
  67. JINDAL A, Mukund A
    Management of Portal Vein Thrombosis in Cirrhosis-Need a Closer Look!
    Am J Gastroenterol. 2021 Jun 30. pii: 00000434-990000000-00025.
    PubMed    


  68. ZHAI LL, Tang ZG
    Effect of Vitamin D Supplementation on Vitamin D Level and Bone Mineral Density in Patients With Cirrhosis: Several Confounding Factors.
    Am J Gastroenterol. 2021 Jun 23. pii: 00000434-990000000-00016.
    PubMed    


  69. REIG A, Alvarez-Navascues C, Vergara M, Gomez-Dominguez E, et al
    Obeticholic Acid and Fibrates in Primary Biliary Cholangitis: Comparative Effects in a Multicentric Observational Study.
    Am J Gastroenterol. 2021 Jun 23. pii: 00000434-990000000-00017.
    PubMed     Abstract available


  70. ACHARYA C, Nadhem O, Shaw J, Hassouneh R, et al
    Liver-Unrelated Comorbid Conditions Do Not Affect Cognitive Performance or Hepatic Encephalopathy Progression in Cirrhosis.
    Am J Gastroenterol. 2021 Jun 18. pii: 00000434-990000000-00012.
    PubMed     Abstract available


  71. LOUISSAINT J, May FP, Williams S, Tapper EB, et al
    Effective Mentorship as a Means to Recruit, Retain, and Promote Underrepresented Minorities in Academic Gastroenterology and Hepatology.
    Am J Gastroenterol. 2021;116:1110-1113.
    PubMed    


  72. CRAVEN LJ, Parvathy SN, Burton JP, Silverman MS, et al
    Response to Ianiro et al.
    Am J Gastroenterol. 2021;116:1361-1362.
    PubMed    


  73. IANIRO G, Porcari S, Gasbarrini A, Cammarota G, et al
    Quantity of Donor Stool for Fecal Microbiota Transplantation: The More, the Better?
    Am J Gastroenterol. 2021;116:1360-1361.
    PubMed    


  74. BENMASSAOUD A, Tsochatzis E
    Response to Debnath and Rathi.
    Am J Gastroenterol. 2021;116:1358-1359.
    PubMed    


  75. DEBNATH P, Rathi P
    Sarcopenia and TIPS: How Best to Measure Muscle Mass.
    Am J Gastroenterol. 2021;116:1358.
    PubMed    


  76. WU F, Pahkala K, Juonala M, Jaakkola J, et al
    Childhood and Adulthood Passive Smoking and Nonalcoholic Fatty Liver in Midlife: A 31-year Cohort Study.
    Am J Gastroenterol. 2021;116:1256-1263.
    PubMed     Abstract available


    May 2021
  77. HERNANDEZ-CONDE M, Llop E, Gomez-Pimpollo L, Fernandez Carrillo C, et al
    Adding Branched-Chain Amino Acids to an Enhanced Standard-of-Care Treatment Improves Muscle Mass of Cirrhotic Patients With Sarcopenia: A Placebo-Controlled Trial.
    Am J Gastroenterol. 2021 May 26. pii: 00000434-900000000-98756.
    PubMed     Abstract available


  78. FARUQUI S, Okoli FC, Olsen SK, Feldman DM, et al
    Cholangiopathy After Severe COVID-19: Clinical Features and Prognostic Implications.
    Am J Gastroenterol. 2021 May 17. pii: 00000434-900000000-98779.
    PubMed     Abstract available


  79. JOHN BV, Khakoo NS, Schwartz KB, Aitchenson G, et al
    Ursodeoxycholic Acid Response Is Associated With Reduced Mortality in Primary Biliary Cholangitis With Compensated Cirrhosis.
    Am J Gastroenterol. 2021 May 13. pii: 00000434-900000000-98782.
    PubMed     Abstract available


  80. GOET JC, Murillo Perez CF, Harms MH, Floreani A, et al
    A Comparison of Prognostic Scores (Mayo, UK-PBC, and GLOBE) in Primary Biliary Cholangitis.
    Am J Gastroenterol. 2021 May 4. pii: 00000434-900000000-98792.
    PubMed     Abstract available


  81. WANG R, Yang L, Hu C, Yan J, et al
    A Tip of the Iceberg on the Mechanism of SARS-CoV-2-Induced Liver Injury.
    Am J Gastroenterol. 2021;116:1097-1098.
    PubMed    


  82. BENMASSAOUD A, Tsochatzis E
    Response to Anand and Sharma.
    Am J Gastroenterol. 2021;116:1094-1095.
    PubMed    


  83. BJORNSSON HK, Bjornsson ES
    Database Studies on Drug-Induced Liver Injury: The Importance of Causality Assessment.
    Am J Gastroenterol. 2021;116:1090-1091.
    PubMed    


  84. CHALASANI NP, Maddur H, Russo MW, Wong RJ, et al
    ACG Clinical Guideline: Diagnosis and Management of Idiosyncratic Drug-Induced Liver Injury.
    Am J Gastroenterol. 2021;116:878-898.
    PubMed     Abstract available


  85. VILAR-GOMEZ E, Pirola CJ, Sookoian S, Wilson LA, et al
    Impact of the Association Between PNPLA3 Genetic Variation and Dietary Intake on the Risk of Significant Fibrosis in Patients With NAFLD.
    Am J Gastroenterol. 2021;116:994-1006.
    PubMed     Abstract available


  86. YATACO ML, Bowman AW, Keaveny AP
    Management of the Incidental Liver Lesion.
    Am J Gastroenterol. 2021;116:855-861.
    PubMed    


  87. ESLAM M, Wong GL, Hashem AM, Chan HL, et al
    A Sequential Algorithm Combining ADAPT and Liver Stiffness Can Stage Metabolic-Associated Fatty Liver Disease in Hospital-Based and Primary Care Patients.
    Am J Gastroenterol. 2021;116:984-993.
    PubMed     Abstract available


    April 2021
  88. GROVER I, Gunjan D, Singh N, Benjamin J, et al
    Effect of Vitamin D Supplementation on Vitamin D Level and Bone Mineral Density in Patients With Cirrhosis: A Randomized Clinical Trial.
    Am J Gastroenterol. 2021 Apr 29. pii: 00000434-900000000-98797.
    PubMed     Abstract available


  89. TRAN S, Jeong D, Henry L, Cheung RC, et al
    Initial Evaluation, Long-Term Monitoring, and Hepatocellular Carcinoma Surveillance of Chronic Hepatitis B in Routine Practice: A Nationwide US Study.
    Am J Gastroenterol. 2021 Apr 29. pii: 00000434-900000000-98796.
    PubMed     Abstract available


  90. THORNTON C, Somayaji R, Parkins M, Swain MG, et al
    Characteristics and Outcomes of Children With Cystic Fibrosis Hospitalized With Cirrhosis in the United States.
    Am J Gastroenterol. 2021 Apr 29. pii: 00000434-900000000-98795.
    PubMed     Abstract available


  91. MA C, Qian AS, Nguyen NH, Stukalin I, et al
    Trends in the Economic Burden of Chronic Liver Diseases and Cirrhosis in the United States: 1996-2016.
    Am J Gastroenterol. 2021 Apr 28. doi: 10.14309/ajg.0000000000001292.
    PubMed     Abstract available


  92. KAWAGUCHI Y, Hasegawa K, Hagiwara Y, De Bellis M, et al
    Effect of Diameter and Number of Hepatocellular Carcinomas on Survival After Resection, Transarterial Chemoembolization, and Ablation.
    Am J Gastroenterol. 2021 Apr 21. pii: 00000434-900000000-98811.
    PubMed     Abstract available


  93. SERPER M, Reddy KR, Bewtra M, Ahmad N, et al
    COVID-19 Vaccine Perceptions Among Patients With Chronic Disease in a Large Gastroenterology and Hepatology Practice.
    Am J Gastroenterol. 2021 Apr 19. pii: 00000434-900000000-98813.
    PubMed     Abstract available


  94. SHARMA S, Saraya A
    Avoiding Beta Blockers in Patients of Hepatitis C Virus-Related Compensated Cirrhosis With Clinically Significant Portal Hypertension After Cure With Antivirals: Are We There Yet?
    Am J Gastroenterol. 2021 Apr 9. pii: 00000434-900000000-98829.
    PubMed    


  95. KHALILI M, Kleiner DE, King WC, Sterling RK, et al
    Hepatic Steatosis and Steatohepatitis in a Large North American Cohort of Adults With Chronic Hepatitis B.
    Am J Gastroenterol. 2021 Apr 8. pii: 00000434-900000000-98823.
    PubMed     Abstract available


  96. SONI D, Roy A, De A, Verma N, et al
    MASQ-HE: Unmasking the Predictors of Overt Hepatic Encephalopathy?
    Am J Gastroenterol. 2021;116:836-837.
    PubMed    


  97. MORTON A
    Measuring Serum Sodium in Cirrhosis: Regarding "Hyponatremia in Cirrhosis: An Update".
    Am J Gastroenterol. 2021;116:835.
    PubMed    


  98. PONS M, Augustin S, Scheiner B, Guillaume M, et al
    Noninvasive Diagnosis of Portal Hypertension in Patients With Compensated Advanced Chronic Liver Disease.
    Am J Gastroenterol. 2021;116:723-732.
    PubMed     Abstract available


  99. LAI JC, Dodge JL, Kappus MR, Wong R, et al
    A Multicenter Pilot Randomized Clinical Trial of a Home-Based Exercise Program for Patients With Cirrhosis: The Strength Training Intervention (STRIVE).
    Am J Gastroenterol. 2021;116:717-722.
    PubMed     Abstract available


  100. KOTANI K, Uchida-Kobayashi S, Yoshida K, Kawamura E, et al
    Lenvatinib-Induced Tumor-Related Hemorrhage in Patients With Unresectable Hepatocellular Carcinoma.
    Am J Gastroenterol. 2021;116:631.
    PubMed    


  101. TAPPER EB
    Finding Common Ground With Our MASQs Off.
    Am J Gastroenterol. 2021;116:837.
    PubMed    


  102. ALUKAL JJ, Thuluvath PJ
    Reply to Morton.
    Am J Gastroenterol. 2021;116:835-836.
    PubMed    


  103. YAMADA G, Hagiwara Y, Kimura T, Takeuchi Y, et al
    Impact of Body Weight Gain on the Incidence of Nonalcoholic Fatty Liver Disease in Nonobese Japanese Individuals.
    Am J Gastroenterol. 2021;116:733-740.
    PubMed     Abstract available


  104. KOK B, McNeely M, Watt M, Tandon P, et al
    Exercise Only Works If You Do It! The Holy Grail of Adherence.
    Am J Gastroenterol. 2021;116:673-674.
    PubMed     Abstract available


    March 2021
  105. ROGAL S, Youk A, Agbalajobi O, Zhang H, et al
    Medication Treatment of Active Opioid Use Disorder in Veterans With Cirrhosis.
    Am J Gastroenterol. 2021 Mar 30. pii: 00000434-900000000-98834.
    PubMed     Abstract available


  106. AYOUB F, Ouni A, Case R, Ladna M, et al
    Dissemination of Gastroenterology and Hepatology Research on Social Media Platforms Is Associated With Increased Citation Count.
    Am J Gastroenterol. 2021 Mar 22. pii: 00000434-900000000-98848.
    PubMed     Abstract available


  107. JANSSON-KNODELL CL, Calderon G, Weber R, Ghabril M, et al
    Small Intestine Varices in Cirrhosis at a High-Volume Liver Transplant Center: A Retrospective Database Study and Literature Review.
    Am J Gastroenterol. 2021 Mar 10. pii: 00000434-900000000-98858.
    PubMed     Abstract available


  108. CHANDEL S, Singh V
    Hyponatremia in Cirrhosis: Role of Vasopressors.
    Am J Gastroenterol. 2021 Mar 10. pii: 00000434-900000000-98857.
    PubMed    


  109. NAM H, Lee SW, Kwon JH, Lee HL, et al
    Prediction of Hepatocellular Carcinoma by On-Therapy Response of Noninvasive Fibrosis Markers in Chronic Hepatitis B.
    Am J Gastroenterol. 2021 Mar 10. pii: 00000434-900000000-98856.
    PubMed     Abstract available


  110. GIL-GOMEZ A, Ampuero J, Rojas A, Gallego-Duran R, et al
    Development and Validation of a Clinical-Genetic Risk Score to Predict Hepatic Encephalopathy in Patients With Liver Cirrhosis.
    Am J Gastroenterol. 2021 Mar 2. pii: 00000434-900000000-98817.
    PubMed     Abstract available


  111. WONG RJ, Jain MK, Therapondos G, Niu B, et al
    Antiviral Therapy Reduces Risk of Cirrhosis in Noncirrhotic HBV Patients Among 4 Urban Safety-Net Health Systems.
    Am J Gastroenterol. 2021 Mar 1. pii: 00000434-900000000-98873.
    PubMed     Abstract available


  112. BRAILLON A
    Hepatocellular Carcinoma in Women: Could Tobacco Matter More than Sex?
    Am J Gastroenterol. 2021;116:617.
    PubMed    


  113. SUBRAMANIAM M, Azad N, Wasan SK, Long MT, et al
    Equal Opportunity: Women Representation on Editorial Boards and Authorship of Editorials in Gastroenterology and Hepatology Journals.
    Am J Gastroenterol. 2021;116:613-616.
    PubMed     Abstract available


  114. MONROSE E, Bui A, Rosenbluth E, Dickstein D, et al
    Burden of Future Liver Abnormalities in Patients With Intrahepatic Cholestasis of Pregnancy.
    Am J Gastroenterol. 2021;116:568-575.
    PubMed     Abstract available


  115. SHAUKAT A, Oxentenko AS
    The Time Is Now to Understand and Address Sex-Related Disparities in Gastroenterology and Hepatology.
    Am J Gastroenterol. 2021;116:441-443.
    PubMed     Abstract available


  116. PHIPPS M, Wattacheril J
    Response to Braillon.
    Am J Gastroenterol. 2021;116:617-618.
    PubMed    


  117. VALENTIN N, Guerrido I, Rozenshteyn F, Pinotti R, et al
    Pregnancy Outcomes After Liver Transplantation: A Systematic Review and Meta-Analysis.
    Am J Gastroenterol. 2021;116:491-504.
    PubMed     Abstract available


    February 2021
  118. BAJAJ JS
    The Three Villages of Hepatic Encephalopathy.
    Am J Gastroenterol. 2021 Feb 26. pii: 00000434-900000000-98870.
    PubMed     Abstract available


  119. LV Y, Bai W, Li K, Wang Z, et al
    Anticoagulation and Transjugular Intrahepatic Portosystemic Shunt for the Management of Portal Vein Thrombosis in Cirrhosis: A Prospective Observational Study.
    Am J Gastroenterol. 2021 Feb 25. pii: 00000434-900000000-98874.
    PubMed     Abstract available


  120. TOSETTI G, Degasperi E, Farina E, D'Ambrosio R, et al
    Decompensation in Direct-Acting Antiviral Cured Hepatitis C Virus Compensated Patients With Clinically Significant Portal Hypertension: Too Rare to Warrant Universal Beta-Blocker Therapy.
    Am J Gastroenterol. 2021 Feb 18. pii: 00000434-900000000-98881.
    PubMed     Abstract available


  121. TAN HK, Teng MLP, Soh AYS, Cheo SHY, et al
    Poor Outcomes of Cirrhosis due to Nonalcoholic Steatohepatitis Compared With Hepatitis B After Decompensation With Ascites.
    Am J Gastroenterol. 2021 Feb 1. doi: 10.14309/ajg.0000000000001176.
    PubMed     Abstract available


    January 2021
  122. SAWAS T, Dilmaghani S, Dhaliwal L, Wang KK, et al
    Risk Factor Profiles Can Distinguish Esophageal Adenocarcinoma From Barrett's Esophagus.
    Am J Gastroenterol. 2021;116:198-201.
    PubMed     Abstract available


  123. LEE JI, Lee HW, Lee KS, Lee HS, et al
    Effects of Statin Use on the Development and Progression of Nonalcoholic Fatty Liver Disease: A Nationwide Nested Case-Control Study.
    Am J Gastroenterol. 2021;116:116-124.
    PubMed     Abstract available


    December 2020
  124. LAI JC, Dodge JL, Kappus MR, Wong R, et al
    A Multicenter Pilot Randomized Clinical Trial of a Home-Based Exercise Program for Patients With Cirrhosis: The Strength Training Intervention (STRIVE).
    Am J Gastroenterol. 2020;Publish Ahead of Print.
    PubMed     Abstract available


  125. YOUNOSSI ZM, Noureddin M, Bernstein D, Kwo P, et al
    Role of Noninvasive Tests in Clinical Gastroenterology Practices to Identify Patients With Nonalcoholic Steatohepatitis at High Risk of Adverse Outcomes: Expert Panel Recommendations.
    Am J Gastroenterol. 2020 Dec 7. doi: 10.14309/ajg.0000000000001054.
    PubMed     Abstract available


    November 2020
  126. KIM NJ, Jacob DA, Ioannou GN, John BV, et al
    Rates and Predictors of Undergoing Different Hepatocellular Carcinoma Screening Tests in Patients With Cirrhosis.
    Am J Gastroenterol. 2020 Nov 26. doi: 10.14309/ajg.0000000000001000.
    PubMed     Abstract available


  127. SHARMA S, Agarwal S, Anand A
    Noninvasive Diagnosis of Clinically Significant Portal Hypertension in Patients With Compensated Liver Disease: Whom and How to Screen?
    Am J Gastroenterol. 2020 Nov 23. doi: 10.14309/ajg.0000000000001078.
    PubMed    


  128. ANAND A, Sharma S
    Sarcopenia Does Not Worsen Outcomes in Patients With Refractory Ascites Under Transjugular Intrahepatic Portosystemic Shunt Placement-Preliminary Evidence?
    Am J Gastroenterol. 2020 Nov 10. doi: 10.14309/ajg.0000000000001053.
    PubMed    


  129. BENMASSAOUD A, Roccarina D, Arico F, Leandro G, et al
    Sarcopenia Does Not Worsen Survival in Patients With Cirrhosis Undergoing Transjugular Intrahepatic Portosystemic Shunt for Refractory Ascites.
    Am J Gastroenterol. 2020;115:1911-1914.
    PubMed     Abstract available


  130. CHEDID VG, Kamath AA, M Knudsen J, Frimannsdottir K, et al
    Three-Dimensional-Printed Liver Model Helps Learners Identify Hepatic Subsegments: A Randomized-Controlled Cross-Over Trial.
    Am J Gastroenterol. 2020;115:1906-1910.
    PubMed     Abstract available


  131. ARE VS, Knapp SM, Banerjee A, Shamseddeen H, et al
    Improving Outcomes of Bariatric Surgery in Patients With Cirrhosis in the United States: A Nationwide Assessment.
    Am J Gastroenterol. 2020;115:1849-1856.
    PubMed     Abstract available


  132. ALUKAL JJ, John S, Thuluvath PJ
    Hyponatremia in Cirrhosis: An Update.
    Am J Gastroenterol. 2020;115:1775-1785.
    PubMed     Abstract available


  133. AHMED O, Pillai A
    Hepatocellular Carcinoma: A Contemporary Approach to Locoregional Therapy.
    Am J Gastroenterol. 2020;115:1733-1736.
    PubMed    


    October 2020
  134. LIU W, Wang S, Guo J, Liu X, et al
    A Bolt Method of Treating the Stent Migration After Endoscopic Ultrasound-Guided Hepaticogastrostomy.
    Am J Gastroenterol. 2020 Oct 28. doi: 10.14309/ajg.0000000000000938.
    PubMed    


  135. LEE BP, Dodge JL, Terrault NA
    Excess Mortality After Liver Transplantation in Young Women With Alcohol-Associated Liver Disease.
    Am J Gastroenterol. 2020 Oct 28. doi: 10.14309/ajg.0000000000001007.
    PubMed     Abstract available


  136. THULUVATH PJ, To C, Amjad W
    Role of Locoregional Therapies in Patients With Hepatocellular Cancer Awaiting Liver Transplantation.
    Am J Gastroenterol. 2020 Oct 23. doi: 10.14309/ajg.0000000000000999.
    PubMed     Abstract available


  137. MORTON A
    Measuring Serum Sodium in Cirrhosis: Regarding "Hyponatremia in Cirrhosis: An Update".
    Am J Gastroenterol. 2020 Oct 19. doi: 10.14309/ajg.0000000000001011.
    PubMed    


  138. SONI D, Roy A, De A, Verma N, et al
    MASQ-HE: Unmasking the Predictors of Overt Hepatic Encephalopathy?
    Am J Gastroenterol. 2020 Oct 19. doi: 10.14309/ajg.0000000000001010.
    PubMed    


  139. ARE VS, Knapp SM, Banerjee A, Shamseddeen H, et al
    Improving Outcomes of Bariatric Surgery in Patients With Cirrhosis in the United States: A Nationwide Assessment.
    Am J Gastroenterol. 2020 Oct 19. doi: 10.14309/ajg.0000000000000911.
    PubMed     Abstract available


  140. KIM JH, Kim DJ, Kwon CI
    Pseudoaneurysmal Rupture of the Hepatic Artery Caused by a Biliary Plastic Stent.
    Am J Gastroenterol. 2020 Oct 15. doi: 10.14309/ajg.0000000000000982.
    PubMed    


  141. REIG A, Norman GL, Pares A
    Surrogate Markers for Antimitochondrial Antibody Negative Primary Biliary Cholangitis.
    Am J Gastroenterol. 2020 Oct 15. doi: 10.14309/ajg.0000000000000980.
    PubMed    


  142. OZDOGAN E, Doganay L, Can D, Arikan C, et al
    Disease Course and Treatment Response of Eosinophilic Gastrointestinal Diseases in Children With Liver Transplantation: Long-Term Follow-Up.
    Am J Gastroenterol. 2020 Oct 13. doi: 10.14309/ajg.0000000000000934.
    PubMed     Abstract available


  143. BENMASSAOUD A, Roccarina D, Arico F, Leandro G, et al
    Sarcopenia Does Not Worsen Survival in Patients With Cirrhosis Undergoing Transjugular Intrahepatic Portosystemic Shunt for Refractory Ascites.
    Am J Gastroenterol. 2020 Oct 12. doi: 10.14309/ajg.0000000000000959.
    PubMed     Abstract available


  144. HU C, Anjur V, Saboo K, Reddy KR, et al
    Low Predictability of Readmissions and Death Using Machine Learning in Cirrhosis.
    Am J Gastroenterol. 2020 Oct 8. doi: 10.14309/ajg.0000000000000971.
    PubMed     Abstract available


  145. PILLAI A, Ahn J, Kulik L
    Integrating Genomics Into Clinical Practice in Hepatocellular Carcinoma: The Challenges Ahead.
    Am J Gastroenterol. 2020 Oct 8. doi: 10.14309/ajg.0000000000000843.
    PubMed     Abstract available


  146. PONS M, Augustin S, Scheiner B, Guillaume M, et al
    Noninvasive Diagnosis of Portal Hypertension in Patients With Compensated Advanced Chronic Liver Disease.
    Am J Gastroenterol. 2020 Oct 8. doi: 10.14309/ajg.0000000000000994.
    PubMed     Abstract available


  147. KALAMBOKIS GN, Tsiakas I, Filippas-Ntekuan S, Christaki M, et al
    Empagliflozin Eliminates Refractory Ascites and Hepatic Hydrothorax in a Patient With Primary Biliary Cirrhosis.
    Am J Gastroenterol. 2020 Oct 7. doi: 10.14309/ajg.0000000000000995.
    PubMed    


  148. CHEN PT, Tzeng HL, Wang HP, Liu KL, et al
    Caput Medusae Bleeding.
    Am J Gastroenterol. 2020;115:1570.
    PubMed    


    September 2020
  149. AHMED O, Pillai A
    Hepatocellular Carcinoma: A Contemporary Approach to Locoregional Therapy.
    Am J Gastroenterol. 2020 Sep 30. doi: 10.14309/ajg.0000000000000931.
    PubMed    


  150. GRANITO A, Muratori L, Tovoli F, Muratori P, et al
    Surrogate Markers for Antimitochondrial Antibody-Negative Primary Biliary Cholangitis.
    Am J Gastroenterol. 2020 Sep 28. doi: 10.14309/ajg.0000000000000928.
    PubMed    


  151. WONG RJ, Saab S, Konyn P, Sundaram V, et al
    Rural-Urban Geographical Disparities in Hepatocellular Carcinoma Incidence Among US Adults, 2004-2017.
    Am J Gastroenterol. 2020 Sep 24. doi: 10.14309/ajg.0000000000000948.
    PubMed     Abstract available


  152. CHEDID VG, Kamath AA, M Knudsen J, Frimannsdottir K, et al
    Three-Dimensional-Printed Liver Model Helps Learners Identify Hepatic Subsegments: A Randomized-Controlled Cross-Over Trial.
    Am J Gastroenterol. 2020 Sep 24. doi: 10.14309/ajg.0000000000000958.
    PubMed     Abstract available


  153. CARBALLO-FOLGOSO L, Alvarez-Navascues C, Rodriguez M
    Acute Liver Failure Associated With Ulipristal Acetate: A Case Report.
    Am J Gastroenterol. 2020;115:1542-1544.
    PubMed    


  154. KIM D, Vazquez-Montesino LM, Escober JA, Fernandes CT, et al
    Low Thyroid Function in Nonalcoholic Fatty Liver Disease Is an Independent Predictor of All-Cause and Cardiovascular Mortality.
    Am J Gastroenterol. 2020;115:1496-1504.
    PubMed     Abstract available


  155. ZHAO J, Blais JE, Chui CSL, Suh IH, et al
    Association Between Nonvitamin K Antagonist Oral Anticoagulants or Warfarin and Liver Injury: A Cohort Study.
    Am J Gastroenterol. 2020;115:1513-1524.
    PubMed     Abstract available


    August 2020
  156. WHITFIELD JB, Masson S, Liangpunsakul S, Mueller S, et al
    Obesity, Diabetes, Coffee, Tea, and Cannabis Use Alter Risk for Alcohol-Related Cirrhosis in 2 Large Cohorts of High-Risk Drinkers.
    Am J Gastroenterol. 2020 Aug 31. doi: 10.14309/ajg.0000000000000833.
    PubMed     Abstract available


  157. CAO Z, Liu Y, Cai M, Xu Y, et al
    The Use of NACSELD and EASL-CLIF Classification Systems of ACLF in the Prediction of Prognosis in Hospitalized Patients With Cirrhosis.
    Am J Gastroenterol. 2020 Aug 27. doi: 10.14309/ajg.0000000000000771.
    PubMed     Abstract available


  158. YE L, Zhang C, Seidensticker M, Mayerle J, et al
    Durable Complete Response of Brain Metastasis From Hepatocellular Carcinoma On Treatment With Nivolumab and Radiation Treatment.
    Am J Gastroenterol. 2020 Aug 26. doi: 10.14309/ajg.0000000000000800.
    PubMed    


  159. LOPEZ-TOBARUELA JM, Valverde-Lopez F, Lopez de Hierro-Ruiz M, Redondo-Cerezo E, et al
    Hepatic Abscess After Biodegradable Esophageal Stent Placement: A Rare Complication.
    Am J Gastroenterol. 2020 Aug 19. doi: 10.14309/ajg.0000000000000821.
    PubMed    


  160. TAPPER EB, Zhao L, Nikirk S, Baki J, et al
    Incidence and Bedside Predictors of the First Episode of Overt Hepatic Encephalopathy in Patients With Cirrhosis.
    Am J Gastroenterol. 2020 Aug 6. doi: 10.14309/ajg.0000000000000762.
    PubMed     Abstract available


  161. ALUKAL JJ, John S, Thuluvath PJ
    Hyponatremia in Cirrhosis: An Update.
    Am J Gastroenterol. 2020 Aug 6. doi: 10.14309/ajg.0000000000000786.
    PubMed     Abstract available


  162. REVERTER E, Ott P
    Compensated Cirrhosis and 20 mm Hg: A Point of No Return?
    Am J Gastroenterol. 2020 Aug 5. doi: 10.14309/ajg.0000000000000770.
    PubMed     Abstract available


  163. ZHANG X, Tang C, Tian D, Hou X, et al
    Management of Digestive Disorders and Procedures Associated With COVID-19.
    Am J Gastroenterol. 2020;115:1153-1155.
    PubMed    


  164. YOUNES R, Govaere O, Petta S, Miele L, et al
    Presence of Serum Antinuclear Antibodies Does Not Impact Long-Term Outcomes in Nonalcoholic Fatty Liver Disease.
    Am J Gastroenterol. 2020;115:1289-1292.
    PubMed     Abstract available


    July 2020
  165. SAMOYLOVA ML, Kapila N, McElroy L, Suhocki P, et al
    Gastrohepatic Fistula After Y-90 Embolization of Hepatocellular Carcinoma.
    Am J Gastroenterol. 2020 Jul 31. doi: 10.14309/ajg.0000000000000793.
    PubMed    


  166. LEVY C, Bowlus CL
    Role of Antinuclear Antibodies in Primary Biliary Cholangitis.
    Am J Gastroenterol. 2020 Jul 22. doi: 10.14309/ajg.0000000000000765.
    PubMed     Abstract available


  167. GAO F, Zheng KI, Fan YC, Targher G, et al
    ACE2: A Linkage for the Interplay Between COVID-19 and Decompensated Cirrhosis.
    Am J Gastroenterol. 2020 Jul 16. doi: 10.14309/ajg.0000000000000780.
    PubMed    


  168. KOTANI K, Uchida-Kobayashi S, Yoshida K, Kawamura E, et al
    Lenvatinib-Induced Tumor-Related Hemorrhage in Patients With Unresectable Hepatocellular Carcinoma.
    Am J Gastroenterol. 2020 Jul 14. doi: 10.14309/ajg.0000000000000747.
    PubMed    


  169. RUBIN JN, Gilman CAL, Gasmi B, Stern WR, et al
    Hepatocellular Carcinoma Where You Least Expect It.
    Am J Gastroenterol. 2020;115:1134-1136.
    PubMed    


  170. BAJAJ JS, Brenner DM, Cai Q, Cash BD, et al
    Major Trends in Gastroenterology and Hepatology Between 2010 and 2019: An Overview of Advances From the Past Decade Selected by the Editorial Board of The American Journal of Gastroenterology.
    Am J Gastroenterol. 2020;115:1007-1018.
    PubMed    


  171. BAJAJ JS, Lauridsen M, Tapper EB, Duarte-Rojo A, et al
    Important Unresolved Questions in the Management of Hepatic Encephalopathy: An ISHEN Consensus.
    Am J Gastroenterol. 2020;115:989-1002.
    PubMed     Abstract available


  172. BOWER RJ, Frenette C
    Reevaluating Goals of Therapy in Primary Biliary Cholangitis: Is Good Enough Is Not Good Enough Anymore?
    Am J Gastroenterol. 2020;115:1024-1025.
    PubMed     Abstract available


  173. CRAVEN L, Rahman A, Nair Parvathy S, Beaton M, et al
    Allogenic Fecal Microbiota Transplantation in Patients With Nonalcoholic Fatty Liver Disease Improves Abnormal Small Intestinal Permeability: A Randomized Control Trial.
    Am J Gastroenterol. 2020;115:1055-1065.
    PubMed     Abstract available


    June 2020
  174. BAJAJ JS, Brenner DM, Cai Q, Cash BD, et al
    Major Trends in Gastroenterology and Hepatology Between 2010 and 2019: An Overview of Advances From the Past Decade Selected by the Editorial Board of The American Journal of Gastroenterology.
    Am J Gastroenterol. 2020 Jun 23. doi: 10.14309/ajg.0000000000000709.
    PubMed    


  175. PARIKH ND, Singal AG, Hutton DW, Tapper EB, et al
    Cost-Effectiveness of Hepatocellular Carcinoma Surveillance: An Assessment of Benefits and Harms.
    Am J Gastroenterol. 2020 Jun 9. doi: 10.14309/ajg.0000000000000715.
    PubMed     Abstract available


  176. KOSHY AN, Farouque O, Gow PJ
    Response to Singh, et al.
    Am J Gastroenterol. 2020;115:951-952.
    PubMed    


  177. MANCUSO A, Amata M, Politi F, Mitra M, et al
    Controversies in Budd-Chiari Syndrome Management: Potential Role of Liver Stiffness.
    Am J Gastroenterol. 2020;115:952-953.
    PubMed    


  178. SAAB S, Kim NG, Lee EW
    Practical Tips on TIPS: When and When Not to Request It.
    Am J Gastroenterol. 2020;115:797-800.
    PubMed    


  179. XU L, Xie J, Chen S, Chen Y, et al
    Light-to-Moderate Alcohol Consumption Is Associated With Increased Risk of Type 2 Diabetes in Individuals With Nonalcoholic Fatty Liver Disease: A Nine-Year Cohort Study.
    Am J Gastroenterol. 2020;115:876-884.
    PubMed     Abstract available


    May 2020
  180. REIG A, Norman GL, Garcia M, Shums Z, et al
    Novel Anti-Hexokinase 1 Antibodies Are Associated With Poor Prognosis in Patients With Primary Biliary Cholangitis.
    Am J Gastroenterol. 2020 May 27. doi: 10.14309/ajg.0000000000000690.
    PubMed     Abstract available


  181. PHIPPS M, Livanos A, Guo A, Pomenti S, et al
    Gender Matters: Characteristics of Hepatocellular Carcinoma in Women From a Large, Multicenter Study in the United States.
    Am J Gastroenterol. 2020 May 22. doi: 10.14309/ajg.0000000000000643.
    PubMed     Abstract available


  182. JINDAL A, Bhardwaj A, Kumar G, Sarin SK, et al
    Clinical Decompensation and Outcomes in Patients With Compensated Cirrhosis and a Hepatic Venous Pressure Gradient >/=20 mm Hg.
    Am J Gastroenterol. 2020 May 21. doi: 10.14309/ajg.0000000000000653.
    PubMed     Abstract available


  183. PATIDAR KR, Shamseddeen H, Xu C, Ghabril MS, et al
    Hospital-Acquired Versus Community-Acquired Acute Kidney Injury in Patients With Cirrhosis: A Prospective Study.
    Am J Gastroenterol. 2020 May 5. doi: 10.14309/ajg.0000000000000670.
    PubMed     Abstract available


  184. VIJAYARAGHAVAN R, Jindal A, Arora V, Choudhary A, et al
    Hemodynamic Effects of Adding Simvastatin to Carvedilol for Primary Prophylaxis of Variceal Bleeding: A Randomized Controlled Trial.
    Am J Gastroenterol. 2020;115:729-737.
    PubMed     Abstract available


    April 2020
  185. RUBIN JN, Gilman CAL, Gasmi B, Stern WR, et al
    Hepatocellular Carcinoma Where You Least Expect It.
    Am J Gastroenterol. 2020 Apr 10. doi: 10.14309/ajg.0000000000000616.
    PubMed    


  186. MOON AM, Kim HP, Barritt AS 4th, Darling J, et al
    A Quality Improvement Initiative Results in Improved Rates of Timely Postvariceal Bleeding Surveillance Endoscopy.
    Am J Gastroenterol. 2020;115:625-628.
    PubMed     Abstract available


  187. HAN E, Lee YH, Kim YD, Kim BK, et al
    Nonalcoholic Fatty Liver Disease and Sarcopenia Are Independently Associated With Cardiovascular Risk.
    Am J Gastroenterol. 2020;115:584-595.
    PubMed     Abstract available


    March 2020
  188. SALIM TI, Nestlerode LC, Lucatorto EL, Wasserman TL, et al
    Frailty as Tested by Gait Speed Is a Risk Factor for Liver Transplant Respiratory Complications.
    Am J Gastroenterol. 2020 Mar 31. doi: 10.14309/ajg.0000000000000609.
    PubMed     Abstract available


  189. BAJAJ JS, Lauridsen M, Tapper EB, Duarte-Rojo A, et al
    Important Unresolved Questions in the Management of Hepatic Encephalopathy: An ISHEN Consensus.
    Am J Gastroenterol. 2020 Mar 30. doi: 10.14309/ajg.0000000000000603.
    PubMed     Abstract available


  190. KAPILA N, Dorsey YC, Shah J, King L, et al
    Transjugular Intrahepatic Portosystemic Shunt for a Challenging Pregnancy.
    Am J Gastroenterol. 2020 Mar 26. doi: 10.14309/ajg.0000000000000602.
    PubMed    


  191. LEE JK, Merchant SA, Schneider JL, Jensen CD, et al
    Proton Pump Inhibitor Use and Risk of Gastric, Colorectal, Liver, and Pancreatic Cancers in a Community-Based Population.
    Am J Gastroenterol. 2020 Mar 20. doi: 10.14309/ajg.0000000000000591.
    PubMed     Abstract available


    February 2020
  192. DAI C, Jiang M
    Women With Nonalcoholic Fatty Liver Disease Lose Protection Against Cardiovascular Disease?
    Am J Gastroenterol. 2020;115:303-304.
    PubMed    


  193. MILLER ED, Abu-Sbeih H, Styskel B, Nogueras Gonzalez GM, et al
    Clinical Characteristics and Adverse Impact of Hepatotoxicity due to Immune Checkpoint Inhibitors.
    Am J Gastroenterol. 2020;115:251-261.
    PubMed     Abstract available


    January 2020
  194. GORDON SC, Wu KH, Lindor K, Bowlus CL, et al
    Ursodeoxycholic Acid Treatment Preferentially Improves Overall Survival Among African Americans With Primary Biliary Cholangitis.
    Am J Gastroenterol. 2020 Jan 27. doi: 10.14309/ajg.0000000000000512.
    PubMed     Abstract available


  195. KLOMPENHOUWER AJ, Alblas M, van Rosmalen BV, Haring MPD, et al
    Response to Chen et al.
    Am J Gastroenterol. 2020;115:147-148.
    PubMed    


  196. MOON AM, Yang JY, Barritt AS 4th, Bataller R, et al
    Rising Mortality From Alcohol-Associated Liver Disease in the United States in the 21st Century.
    Am J Gastroenterol. 2020;115:79-87.
    PubMed     Abstract available


  197. SINGAL AK, Arora S, Wong RJ, Satapathy SK, et al
    Increasing Burden of Acute-On-Chronic Liver Failure Among Alcohol-Associated Liver Disease in the Young Population in the United States.
    Am J Gastroenterol. 2020;115:88-95.
    PubMed     Abstract available


  198. DANG K, Hirode G, Singal AK, Sundaram V, et al
    Alcoholic Liver Disease Epidemiology in the United States: A Retrospective Analysis of 3 US Databases.
    Am J Gastroenterol. 2020;115:96-104.
    PubMed     Abstract available


    November 2019
  199. CAZZAGON N, Lemoinne S, El Mouhadi S, Trivedi PJ, et al
    The Complementary Value of Magnetic Resonance Imaging and Vibration-Controlled Transient Elastography for Risk Stratification in Primary Sclerosing Cholangitis.
    Am J Gastroenterol. 2019 Nov 14. doi: 10.14309/ajg.0000000000000461.
    PubMed     Abstract available


  200. ALLEN AM, Therneau TM, Mara KC, Larson JJ, et al
    Women With Nonalcoholic Fatty Liver Disease Lose Protection Against Cardiovascular Disease: A Longitudinal Cohort Study.
    Am J Gastroenterol. 2019;114:1764-1771.
    PubMed     Abstract available


  201. HARRIS R, Card TR, Delahooke T, Aithal GP, et al
    Obesity Is the Most Common Risk Factor for Chronic Liver Disease: Results From a Risk Stratification Pathway Using Transient Elastography.
    Am J Gastroenterol. 2019;114:1744-1752.
    PubMed     Abstract available


    June 2019
  202. YOKODA RT, Carey EJ
    Primary Biliary Cholangitis and Primary Sclerosing Cholangitis.
    Am J Gastroenterol. 2019 Jun 4. doi: 10.14309/ajg.0000000000000268.
    PubMed     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Liver Diseases is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: